CLOV
Clover Health Investments, Corp.
Price Chart
Latest Quote
$4.76
+0.13 (+2.81%)
Current Price
| Previous Close | $4.63 |
| Open | $4.72 |
| Day High | $4.83 |
| Day Low | $4.67 |
| Volume | 362,408 |
Stock Information
| Shares Outstanding | 435.44M |
| Cash Equivalents | $243.10M |
| Revenue | $2.48B |
| Net Income | $-18.36M |
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Market Cap | $2.53B |
| EPS (TTM) | $-0.05 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $2.22B |
| Sales | $2.48B |
| Income | $-18.36M |
| Book/sh | $0.71 |
| Cash/sh | $0.56 |
| Employees | 724 |
Financial Ratios
| Quick Ratio | 1.38 |
| Current Ratio | 1.50 |
Returns & Margins
| ROA | -1.77% |
| ROE | -5.10% |
| Gross Margin | 18.54% |
| Operating Margin | 3.77% |
| Profit Margin | -0.74% |
Ownership
| Insider Ownership | 4.19% |
| Institutional Ownership | 33.92% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 31.73 |
| P/S | 1.02 |
| P/B | 6.69 |
Analyst Data
| Recommendation | none |
| Target Price | $5.38 |
Technical Indicators
| SMA20 | $4.63 |
| SMA50 | $4.49 |
| SMA200 | $3.52 |
| RSI | 56.34 |
| ATR | 0.2360 |
| Shares Float | 412.70M |
| Short Float | 6.18% |
| Short Ratio | 5.73 |
| Volatility | 2.46 |
| Rel Volume | 0.09 |
Performance History
| Week | -0.42% |
| Month | +10.06% |
| Quarter | +9.68% |
| 6 Months | +84.50% |
| YTD | +97.51% |
| Year | +24.93% |
| 3 Years | +415.71% |
| 5 Years | -39.29% |
| 10 Years | -53.33% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-28 | $4.76 | 362,408 |
| 2026-10-27 | $4.63 | 3,046,800 |
| 2026-10-26 | $4.56 | 2,489,400 |
| 2026-10-23 | $4.60 | 3,317,500 |
| 2026-10-22 | $4.73 | 3,189,500 |
| 2026-10-21 | $4.78 | 3,177,700 |
| 2026-10-20 | $4.80 | 3,496,100 |
| 2026-10-19 | $4.44 | 3,813,700 |
| 2026-10-16 | $4.48 | 3,717,400 |
| 2026-10-15 | $4.68 | 3,368,100 |
| 2026-10-14 | $4.79 | 3,757,000 |
| 2026-10-13 | $4.81 | 3,786,100 |
| 2026-10-12 | $4.78 | 3,893,700 |
| 2026-10-09 | $4.79 | 10,549,400 |
| 2026-10-08 | $4.58 | 5,518,400 |
| 2026-10-07 | $4.56 | 7,423,500 |
| 2026-10-06 | $4.60 | 3,350,500 |
| 2026-10-05 | $4.68 | 4,879,300 |
| 2026-10-02 | $4.38 | 3,855,500 |
| 2026-10-01 | $4.23 | 3,576,300 |
| 2026-09-30 | $4.31 | 3,340,800 |
| 2026-09-29 | $4.32 | 2,652,600 |
| 2026-09-28 | $4.33 | 3,330,500 |
About Clover Health Investments, Corp.
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.
đ° Latest News
No news articles available at the moment. Check back later for updates on CLOV.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,568,406,000 | $1,006,327,000 | $1,004,590,000 | $993,073,000 |
| Cost Of Revenue | $1,568,406,000 | $1,006,327,000 | $1,004,590,000 | $993,073,000 |
| Total Revenue | $1,924,308,000 | $1,371,131,000 | $1,260,543,000 | $1,096,552,000 |
| Operating Revenue | $1,891,732,000 | $1,344,881,000 | $1,235,769,000 | $1,084,869,000 |
| Expenses | ||||
| Interest Expense | $0 | $0 | $7,000 | $1,363,000 |
| Total Expenses | $2,009,837,000 | $1,416,592,000 | $1,440,106,000 | $1,383,216,000 |
| Other Income Expense | $-20,000 | $-805,000 | $-30,578,000 | $33,443,000 |
| Net Non Operating Interest Income Expense | $0 | $0 | $-7,000 | $-1,363,000 |
| Interest Expense Non Operating | $0 | $0 | $7,000 | $1,363,000 |
| Operating Expense | $441,431,000 | $410,265,000 | $435,516,000 | $390,143,000 |
| General And Administrative Expense | $439,745,000 | $408,934,000 | $440,246,000 | $482,403,000 |
| Other Operating Expenses | - | - | $-7,239,000 | $-93,447,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-85,549,000 | $-46,266,000 | $-210,148,000 | $-254,584,000 |
| Net Interest Income | $0 | $0 | $-7,000 | $-1,363,000 |
| Normalized Income | $-85,529,000 | $-45,461,000 | $-179,570,000 | $-288,027,000 |
| Net Income From Continuing And Discontinued Operation | $-85,549,000 | $-43,009,000 | $-213,361,000 | $-339,567,000 |
| Total Operating Income As Reported | $-85,529,000 | $-45,749,000 | $-205,329,000 | $-286,664,000 |
| Net Income Common Stockholders | $-85,549,000 | $-43,009,000 | $-213,361,000 | $-339,567,000 |
| Net Income | $-85,549,000 | $-43,009,000 | $-213,361,000 | $-339,567,000 |
| Net Income Including Noncontrolling Interests | $-85,549,000 | $-43,009,000 | $-213,361,000 | $-339,567,000 |
| Net Income Discontinuous Operations | $0 | $3,257,000 | $-3,213,000 | $-84,983,000 |
| Net Income Continuous Operations | $-85,549,000 | $-46,266,000 | $-210,148,000 | $-254,584,000 |
| Pretax Income | $-85,549,000 | $-46,266,000 | $-210,148,000 | $-254,584,000 |
| Special Income Charges | $0 | $-288,000 | $-25,766,000 | $23,326,000 |
| Operating Income | $-85,529,000 | $-45,461,000 | $-179,563,000 | $-286,664,000 |
| Depreciation Amortization Depletion Income Statement | $1,686,000 | $1,331,000 | $2,509,000 | $1,187,000 |
| Depreciation And Amortization In Income Statement | $1,686,000 | $1,331,000 | $2,509,000 | $1,187,000 |
| Gross Profit | $355,902,000 | $364,804,000 | $255,953,000 | $103,479,000 |
| Per Share | ||||
| Diluted EPS | $-0.17 | $-0.08 | $-0.44 | $-0.71 |
| Basic EPS | $-0.17 | $-0.08 | $-0.44 | $-0.71 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-83,843,000 | $-44,130,000 | $-177,054,000 | $-285,477,000 |
| Total Unusual Items | $-20,000 | $-805,000 | $-30,578,000 | $33,443,000 |
| Total Unusual Items Excluding Goodwill | $-20,000 | $-805,000 | $-30,578,000 | $33,443,000 |
| Reconciled Depreciation | $1,686,000 | $1,331,000 | $2,509,000 | $1,187,000 |
| EBITDA (Bullshit earnings) | $-83,863,000 | $-44,935,000 | $-207,632,000 | $-252,034,000 |
| EBIT | $-85,549,000 | $-46,266,000 | $-210,141,000 | $-253,221,000 |
| Diluted Average Shares | $511,967,146 | $490,018,730 | $482,176,127 | $476,244,262 |
| Basic Average Shares | $511,967,146 | $490,018,730 | $482,176,127 | $476,244,262 |
| Diluted NI Availto Com Stockholders | $-85,549,000 | $-43,009,000 | $-213,361,000 | $-339,567,000 |
| Impairment Of Capital Assets | $0 | $0 | $15,945,000 | $0 |
| Restructuring And Mergern Acquisition | $0 | $288,000 | $9,821,000 | $0 |
| Gain On Sale Of Security | $-20,000 | $-517,000 | $-4,812,000 | $10,117,000 |
| Selling General And Administration | $439,745,000 | $408,934,000 | $440,246,000 | $482,403,000 |
| Other Gand A | $214,270,000 | $176,480,000 | $183,089,000 | $203,678,000 |
| Salaries And Wages | $225,475,000 | $232,454,000 | $257,157,000 | $278,725,000 |
| Other Special Charges | - | - | - | $-23,326,000 |
Fetched: 2026-10-26
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $305,714,000 | $338,153,000 | $283,404,000 | $336,887,000 |
| Total Assets | $541,011,000 | $580,742,000 | $570,671,000 | $808,620,000 |
| Total Non Current Assets | $233,156,000 | $237,618,000 | $142,701,000 | $183,623,000 |
| Other Non Current Assets | $24,118,000 | $13,259,000 | $13,628,000 | $15,735,000 |
| Investmentin Financial Assets | $199,663,000 | $216,062,000 | $121,001,000 | $138,110,000 |
| Goodwill And Other Intangible Assets | $2,990,000 | $2,990,000 | $2,990,000 | $20,000,000 |
| Other Intangible Assets | $2,990,000 | $2,990,000 | $2,990,000 | $8,251,000 |
| Current Assets | $307,855,000 | $343,124,000 | $427,970,000 | $624,997,000 |
| Other Current Assets | $10,649,000 | $15,603,000 | $18,612,000 | $4,043,000 |
| Prepaid Assets | $18,209,000 | $13,174,000 | $14,418,000 | $18,146,000 |
| Receivables | $158,741,000 | $92,792,000 | $86,240,000 | $167,545,000 |
| Other Receivables | $158,741,000 | $92,792,000 | $86,240,000 | $167,545,000 |
| Cash Cash Equivalents And Short Term Investments | $120,256,000 | $221,555,000 | $236,229,000 | $334,761,000 |
| Cash And Cash Equivalents | $78,301,000 | $194,543,000 | $116,407,000 | $103,791,000 |
| Assets Held For Sale Current | - | $0 | $72,471,000 | - |
| Restricted Cash | - | - | $55,631,000 | $100,502,000 |
| Debt | ||||
| Total Debt | - | - | $4,663,000 | $5,860,000 |
| Long Term Debt And Capital Lease Obligation | - | - | $2,998,000 | $4,033,000 |
| Current Debt And Capital Lease Obligation | - | - | $1,665,000 | $1,827,000 |
| Long Term Debt | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $232,307,000 | $239,599,000 | $284,277,000 | $451,733,000 |
| Total Non Current Liabilities Net Minority Interest | $23,484,000 | $26,083,000 | $23,162,000 | $20,226,000 |
| Other Non Current Liabilities | $23,484,000 | $26,083,000 | $23,162,000 | $16,193,000 |
| Current Liabilities | $208,823,000 | $213,516,000 | $261,115,000 | $431,507,000 |
| Other Current Liabilities | $3,324,000 | $3,466,000 | $65,880,000 | $74,330,000 |
| Payables And Accrued Expenses | $205,499,000 | $210,050,000 | $195,235,000 | $348,111,000 |
| Payables | $189,461,000 | $190,960,000 | $174,284,000 | $324,149,000 |
| Other Payable | $153,250,000 | $156,396,000 | $137,100,000 | $290,138,000 |
| Accounts Payable | $36,211,000 | $34,564,000 | $37,184,000 | $32,445,000 |
| Current Deferred Liabilities | - | - | $3,099,000 | $0 |
| Derivative Product Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $308,704,000 | $341,143,000 | $286,394,000 | $356,887,000 |
| Total Equity Gross Minority Interest | $308,704,000 | $341,143,000 | $286,394,000 | $356,887,000 |
| Stockholders Equity | $308,704,000 | $341,143,000 | $286,394,000 | $356,887,000 |
| Gains Losses Not Affecting Retained Earnings | $528,000 | $-1,584,000 | $-2,370,000 | $-9,374,000 |
| Other Equity Adjustments | $528,000 | $-1,584,000 | $-2,370,000 | $-9,374,000 |
| Retained Earnings | $-2,288,352,000 | $-2,202,803,000 | $-2,159,794,000 | $-1,946,433,000 |
| Preferred Securities Outside Stock Equity | - | - | - | - |
| Other | ||||
| Treasury Shares Number | $33,412,273 | $18,752,947 | $7,912,750 | $2,072,752 |
| Ordinary Shares Number | $519,042,526 | $503,525,356 | $489,051,614 | $478,393,570 |
| Share Issued | $552,454,799 | $522,278,303 | $496,964,364 | $480,466,322 |
| Tangible Book Value | $305,714,000 | $338,153,000 | $283,404,000 | $336,887,000 |
| Invested Capital | $308,704,000 | $341,143,000 | $286,394,000 | $356,887,000 |
| Working Capital | $99,032,000 | $129,608,000 | $166,855,000 | $193,490,000 |
| Total Capitalization | $308,704,000 | $341,143,000 | $286,394,000 | $356,887,000 |
| Treasury Stock | $86,187,000 | $30,991,000 | $12,729,000 | $6,509,000 |
| Additional Paid In Capital | $2,682,663,000 | $2,576,471,000 | $2,461,238,000 | $2,319,157,000 |
| Capital Stock | $52,000 | $50,000 | $49,000 | $46,000 |
| Common Stock | $52,000 | $50,000 | $49,000 | $46,000 |
| Current Accrued Expenses | $16,038,000 | $19,090,000 | $20,951,000 | $23,962,000 |
| Investments And Advances | $199,663,000 | $216,062,000 | $121,001,000 | $138,110,000 |
| Held To Maturity Securities | $12,571,000 | $14,343,000 | $793,000 | $742,000 |
| Available For Sale Securities | $187,092,000 | $201,719,000 | $120,208,000 | $137,368,000 |
| Net PPE | $6,385,000 | $5,307,000 | $5,082,000 | $9,778,000 |
| Accumulated Depreciation | $-7,600,000 | $-5,914,000 | $-4,583,000 | $-2,311,000 |
| Gross PPE | $13,985,000 | $11,221,000 | $9,665,000 | $12,089,000 |
| Leases | $3,035,000 | $3,035,000 | $3,035,000 | $3,035,000 |
| Other Properties | $113,000 | $113,000 | $113,000 | $4,313,000 |
| Machinery Furniture Equipment | $10,837,000 | $8,073,000 | $6,517,000 | $4,741,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $41,955,000 | $27,012,000 | $119,822,000 | $230,970,000 |
| Capital Lease Obligations | - | - | $4,663,000 | $5,860,000 |
| Minority Interest | - | - | $0 | $0 |
| Long Term Capital Lease Obligation | - | - | $2,998,000 | $4,033,000 |
| Current Deferred Revenue | - | - | $3,099,000 | $0 |
| Current Capital Lease Obligation | - | - | $1,665,000 | $1,827,000 |
| Dueto Related Parties Current | - | - | $1,363,000 | $1,566,000 |
| Goodwill | - | - | $0 | $11,749,000 |
| Current Provisions | - | - | - | $7,239,000 |
Fetched: 2026-10-26
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-68,977,000 | $33,289,000 | $-145,246,000 | $-208,393,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-66,934,000 | $34,845,000 | $-144,662,000 | $-203,926,000 |
| Cash From Discontinued Operating Activities | $0 | $-47,605,000 | $-109,514,000 | $100,674,000 |
| Cash Flow From Continuing Operating Activities | $-66,934,000 | $82,450,000 | $-35,148,000 | $-304,600,000 |
| Operating Gains Losses | $-959,000 | $37,000 | $4,792,000 | $-33,176,000 |
| Investing Activities | ||||
| Capital Expenditure | $-2,043,000 | $-1,556,000 | $-584,000 | $-4,467,000 |
| Investing Cash Flow | $4,076,000 | $565,000 | $140,013,000 | $95,133,000 |
| Cash Flow From Continuing Investing Activities | $4,076,000 | $565,000 | $140,013,000 | $95,133,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-55,198,000 | $-18,263,000 | $-6,220,000 | $-6,362,000 |
| Issuance Of Capital Stock | $1,814,000 | $902,000 | $1,150,000 | $1,400,000 |
| Financing Cash Flow | $-53,384,000 | $-17,361,000 | $-5,070,000 | $-4,962,000 |
| Cash Flow From Continuing Financing Activities | $-53,384,000 | $-17,361,000 | $-5,070,000 | $-4,962,000 |
| Net Common Stock Issuance | $-53,384,000 | $-17,361,000 | $-5,070,000 | $-4,962,000 |
| Common Stock Issuance | $1,814,000 | $902,000 | $1,150,000 | $1,400,000 |
| Net Other Financing Charges | - | - | $-28,791,000 | $82,422,000 |
| Other | ||||
| End Cash Position | $78,301,000 | $194,543,000 | $176,494,000 | $186,213,000 |
| Beginning Cash Position | $194,543,000 | $176,494,000 | $186,213,000 | $299,968,000 |
| Changes In Cash | $-116,242,000 | $18,049,000 | $-9,719,000 | $-113,755,000 |
| Common Stock Payments | $-55,198,000 | $-18,263,000 | $-6,220,000 | $-6,362,000 |
| Net Investment Purchase And Sale | $6,119,000 | $2,121,000 | $140,597,000 | $115,800,000 |
| Sale Of Investment | $211,216,000 | $203,362,000 | $316,164,000 | $485,446,000 |
| Purchase Of Investment | $-205,097,000 | $-201,241,000 | $-175,567,000 | $-369,646,000 |
| Net PPE Purchase And Sale | $-2,043,000 | $-1,556,000 | $-584,000 | $-4,467,000 |
| Purchase Of PPE | $-2,043,000 | $-1,556,000 | $-584,000 | $-4,467,000 |
| Change In Working Capital | $-84,197,000 | $12,855,000 | $25,289,000 | $-2,359,000 |
| Change In Other Working Capital | $-3,146,000 | $19,296,000 | $-294,000 | $1,077,000 |
| Change In Other Current Liabilities | $-2,741,000 | $606,000 | $6,404,000 | $-203,000 |
| Change In Other Current Assets | $-5,921,000 | $2,852,000 | $8,859,000 | $-8,208,000 |
| Change In Payables And Accrued Expense | $-1,405,000 | $-4,591,000 | $1,838,000 | $16,419,000 |
| Change In Accrued Expense | $-3,052,000 | $-1,971,000 | $-2,901,000 | $8,784,000 |
| Change In Payable | $1,647,000 | $-2,620,000 | $4,739,000 | $7,635,000 |
| Change In Account Payable | $1,647,000 | $-2,620,000 | $4,739,000 | $7,635,000 |
| Change In Prepaid Assets | $-5,035,000 | $1,244,000 | $3,728,000 | $-3,415,000 |
| Change In Receivables | $-65,949,000 | $-6,552,000 | $4,754,000 | $-8,029,000 |
| Other Non Cash Items | $-1,572,000 | $-3,095,000 | $-4,014,000 | $-1,473,000 |
| Stock Based Compensation | $103,657,000 | $114,331,000 | $140,931,000 | $164,305,000 |
| Provisionand Write Offof Assets | $0 | $0 | $-7,239,000 | $-93,517,000 |
| Asset Impairment Charge | $0 | $0 | $15,945,000 | $0 |
| Depreciation Amortization Depletion | $1,686,000 | $1,331,000 | $2,509,000 | $1,187,000 |
| Depreciation And Amortization | $1,686,000 | $1,331,000 | $2,509,000 | $1,187,000 |
| Gain Loss On Investment Securities | $-959,000 | $37,000 | $4,792,000 | $-9,850,000 |
| Net Income From Continuing Operations | $-85,549,000 | $-43,009,000 | $-213,361,000 | $-339,567,000 |
| Net Business Purchase And Sale | - | $0 | $0 | $-16,200,000 |
| Purchase Of Business | - | $0 | $0 | $-16,200,000 |
| Repayment Of Debt | - | - | $0 | $0 |
| Interest Paid Supplemental Data | - | - | $0 | $0 |
| Proceeds From Stock Option Exercised | - | - | $0 | $0 |
| Net Issuance Payments Of Debt | - | - | $0 | $0 |
| Net Long Term Debt Issuance | - | - | $0 | $0 |
| Long Term Debt Payments | - | - | $0 | $0 |
| Issuance Of Debt | - | - | - | $0 |
| Long Term Debt Issuance | - | - | - | $0 |
| Gain Loss On Sale Of PPE | - | - | - | - |
Fetched: 2026-10-26